Viking Therapeutics announced its oral formulation of VK2735 has scored in a Phase I trial at ObesityWeek 2024.

Viking Therapeutics reported an 8.2% weight loss with VK2735, but a sell-off followed. Read why VKTX stock's long-term ...

Truist Financial analyst Joon Lee assigned a Buy rating to the stock today. The company’s shares closed last Friday at $72.88. Lee covers ...

Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...

The world's richest celebrity chef isn't Gordon Ramsay, based on 2024 data. See the top 21. Scientists Just Discovered a New ...

In related news, the American Diabetes Association released new consensus considerations and good-practice points for use of ...

On Friday, Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $78.03 which represents a slight increase of $4.81 or 6.57% from the prior close of $73.22. The stock opened at ...

On Thursday, Viking Therapeutics Inc (VKTX) stock saw a modest uptick, ending the day at $73.22 which represents a slight increase of $12.83 or 21.25% from the prior close of $60.39. The stock opened ...

Viking Therapeutics, Inc. (VKTX) closed at $65.85 in the latest trading session, marking a +0.72% move from the prior day. The stock's change was more than the S&P 500's daily gain of 0.47%.

Twin 1,000 hp Volvo Penta D13s with IPS drives deliver a top speed of up to 33 knots. One of the most successful sportfishing battlewagons ever built was the Viking 72, a 45-knot speed demon that, ...